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Introduction
Access to therapeutic drugs form an integral part of  
any successful healthcare system. The high cost of  
drugs, however, remains a barrier to accessibility and 
improved health to the majority of  the South Afri-
can population1. The promotion of  generic drug con-
sumption could potentially be an important cost-saving 
mechanism in this regard for final consumers, insurance 
providers, and government. In 2001, the South African 
government subsequently passed  the  law  which  al-
lows  generic  substitution  of   branded  medicines  with 
generics, provided  that  the  patient  approves  of   the 
substitution.  In the discussion over the use of  generic 
drugs, patient perceptions have often been neglected.
Currently  very  little  knowledge  exists  on  the  per-
ception  and  attitudes  of   South  African citizens with 
regard to the use of  generic drugs.     An appraisal of  
the available literature suggests that although patients 
do not completely have a negative opinion of  generic 
drugs and acceptance is growing, there still exists room 
for improving perceptions.
Similar to several international studies, the South Af-
rican patient’s acceptance of  generics is influenced  by 
age, educational level,  perceived   seriousness of  illness, 
generic drug information, and  doctor  and  pharma-
cist  perceptions.  In general, participants with lower 
incomes and participants with lower levels of  education 
held poorer attitudes toward generic drugs2. Individuals 
with tertiary education were found to have  a more  pos-
itive  attitude toward generics than individuals with no 
tertiary education3. 
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Patients  often  confuse  “generic  brands”  of   thera-
peutic  drugs  with  counterfeit  products especially due 
to the cost difference 0associated with these products. 
Free generic medication issued  by  the  public  health 
facilities  are  viewed  as  inferior,  treated  with  sus-
picion  and regarded as being of  poor quality4. There 
are however citizens who view drug quality as product 
attributes and expected consequences of  taking a par-
ticular medicine. Irrespective of  whether  the  drug  was 
a  generic,  original, supplied  for  free  or  purchased 
from  a pharmacy, the drug was considered good quality 
provided that it treated the symptoms.
Studies also consistently show that, participants fre-
quently have very little understanding of  generic 
medicines. Most patients are not adequately informed 
about  the  difference  or similarities between original 
and generic drugs by healthcare providers. Additional-
ly patients feel  that  they  have  limited  influence in 
the  choice  of   generic  substitution.  Patients with 
increased level of  education, and those who received 
proper counselling, were found to be more accepting of  
generic substitution and tended to view generic drugs 
as a valuable reform. Patients would be more inclined 
to choose a generic drug if  the decision was supported 
by their doctor rather than the recommendation of  the 
pharmacist.
The use of  generic drugs to treat chronic diseases is 
also received with mixed acceptance. Certain groups of  
patients viewed the cost saving benefit very positively. 
South African patients also related quality to the abil-
ity of  the medication to do what it was prescribed to 
do. Therefore  drugs  that  treated  their  symptoms 
-  whether  generic  or  original  -  were  fully accepted 
provided they fulfilled their role. On the other hand, 
there were also patients who were not accepting of  ge-
nerics to treat chronic conditions, as they viewed them 
as inferior, and likely to have greater side effects than 
original drugs. Some of  the concerns amongst chron-
ic drug users were with regard to reduced effect of  
the drug or new or increased side effects. In addition, 
chronically ill patients who take several drugs for longer 
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periods of  time admitted to feeling unsettled - particu-
larly when being offered different generics each time 
they purchase their medication. The effect of  brand to 
generic and generic to generic switches leads  to  inten-
tional  non-adherence  in erroneous  use.  This  is es-
pecially  problematic  with medication classes that have 
narrow therapeutic margin like anti–epileptics.
Recommendation
It is strongly evident that more research is required with 
respect to patient perceptions  in relation  to gener-
ic  drug   usage  from  the South African  perspective 
where  cost  saving  is desired more than developed 
countries.
Existing  negative  perceptions  surrounding  the  qual-
ity  of   generic  medicines  need  to  be addressed to 
ensure that patients use them with confidence. A novel 
approach to addressing negative  perceptions  would be 
to institute  national  educational  campaigns  to increase 
the uptake  of   generic  medicines  by  consumers. Gov-
ernment policies  are  destined  to  fail  in execution if  
inadequate attention is paid to consumer perceptions as 
this affects behaviour and consumption patterns.
Policy makers need to emphasize to patients what is 
being done to ensure that generic drugs available in 
the South African market are safe and of  an accept-
able quality. More stringent policy’s should be exerted 
on pharmaceutical companies to ensure that they do 
not produce poor quality medication and they should 
further be held accountable for any inferior products 
reaching the market. 
 
Patient acceptance of  generics improved when they 
were viewed in a positive light by the healthcare pro-
fessionals treating them. For generic substitution poli-
cy to succeed healthcare providers therefore also need 
to adopt a positive attitude toward generics medicine. 
These groups  require  credible  information  with  re-
gard  to  the  products  they  recommend  and dis-
pense.  Since  a  manufacturer’s  reputation  influences 
the  confidence  of   professionals, generic manufactur-
er should provide more robust evidence demonstrating 
therapeutic equivalence  of   their  products.  Efforts 
should  be made  by  generic  companies  to improve 
practitioner and pharmacist  knowledge of  their prod-
ucts. The perceived risks and inequality toward generic 
medicines will decline if  patients have acknowledged 
the benefits of  generic medicines obtained through re-
peated exposure to these products.
Education of  healthcare workers   is imperative and they 
should be made aware of  their role and responsibility in 
improving patient perceptions and reducing healthcare 
costs. Implementation of  present intervention needs to 
target all health care professionals to ensure a consistent 
message is communicated to the wider South African 
public. Polices need to be embraced from a grass route 
level i.e. Universities training healthcare professionals 
and professional bodies and councils.
Finally pharmacovigilance programs can also have  a 
significant  impact  on  increasing confidence in the 
therapeutic equivalence of  generics. Healthcare pro-
fessionals and patients alike should be encouraged to 
report any problems with medication. Furthermore 
appropriate action in response to all reports should 
be implemented. Action must be taken to ensure than 
in the government’s effort to reducing costs of  drugs, 
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